EZH2 and diffuse large B-cell lymphoma: Similar to MEF2B mutations, recurrent mutations affecting the chromatin-modifying enzymes EZH2 and KMT2D (also called MLL2) in DLBCL are also thought to reduce target gene expression14, 39.